{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-085686","form_type":"8-K","ticker":"ALTO","cik":"0000778164","company_name":"Alto Ingredients, Inc.","filed_at":"2026-08-05T20:18:04+00:00","discovered_at":"2026-08-05T20:19:02.170553+00:00","generated_at":"2026-08-05T20:19:23.292890+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alto Ingredients Q2 net income $11.4M vs loss; establishes $50M ATM program","bullets":["Net sales $245.7M, up 12.5% YoY from $218.4M; gross profit $16.6M vs gross loss $1.9M.","Net income $11.4M ($0.15/diluted share) vs net loss $11.3M ($0.15 loss) in Q2 2025.","Adjusted EBITDA $23.7M, improved $23.9M from negative $0.2M in prior-year quarter.","Established $50M at-the-market equity program for financial flexibility and organic growth.","Cash $24.0M; borrowing availability $106M including $41M operating line and $65M term loan."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-085686","json":"https://secwatch.observer/filing/0001213900-26-085686.json","markdown":"https://secwatch.observer/filing/0001213900-26-085686.md","text":"https://secwatch.observer/filing/0001213900-26-085686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/778164/000121390026085686/0001213900-26-085686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/778164/000121390026085686/ea0300669-8k_alto.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:19:23.292890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}